Immunicon’s CellSearch Circulating Tumor Cell (CTC) Kit has received FDA clearance as an aid in the monitoring of patients with metastatic prostate cancer. The kit is now cleared for three of the […]
Global Cancer Consortium
Aesculap to Distribute Misonix BoneScalpel
An example of the precision afforded by Misonix ultrasound cutting technologies: an eggshell is cut and the membrane is left intact. In an agreement finalized Tuesday, Aesculap announced it will distribute the […]
HemeScan: CombiMatrix and Clarient to Advance Personalized Therapies for Chronic Lymphotic Leukemia
More partnering news, this time from CombiMatrix and Clarient, who will market and sell a genomics-based cancer test called HemeScan. HemeScan was developed by CombiMatrix; the test forecasts the probable outcome of […]
A Filtration Collaboration: Delcath and Aethlon to Expand Cancer Treatment Options
Aethlon Medical and Delcath Systems have agreed to jointly research and develop a new filtration cartridge for use in Delcath’s percutaneous hepatic perfusion (“PHP”) system. PHP is a technology designed to isolate […]
BioSphere to Market Microspheres in China
Company eyes large opportunity in treating liver cancer Rockland, MA-based BioSphere Medical reported this week that the Medical Device Department of the People’s Republic of China approved BioSphere’s Embosphere Microspheres for clinical […]
Breast Cancer Screening Co-Pay Could Hurt Insurers’ Bottom Line
A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting potentially life-saving mammograms. The study examined 366,475 […]
New Study Highlights Promising Gene-Based Predictor of Prostate Cancer Risk
Test to be commercialized by Proactive Genomics, LLC In the past few years, novel research tools have emerged which scientist to systematically and objectively evaluate genetic variants in the genome. These new […]
MelaFinding Its Way
Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that its pivotal trial is over two-thirds complete. […]
